Related Experiment Video
Updated: Jun 2, 2026
06:09
Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis
Published on: September 30, 2017
Tularemia vaccines: recent developments and remaining hurdles.
1National Research Council, Institute for Biological Sciences, Ottawa, Ontario, Canada. wayne.conlan@nrc-cnrc.gc.ca
Future Microbiology
|April 30, 2011
Summary
Francisella tularensis subsp. tularensis poses a significant bioterrorism threat due to its low infectious dose and high mortality. This review examines novel vaccine candidates and their development challenges against this dangerous pathogen.
Area of Science:
- Bacteriology
- Immunology
- Vaccinology
Background:
- Francisella tularensis subsp. tularensis is a highly virulent bacterium causing tularemia.
- Inhaled infection has a low dose and high mortality rate.
- Concerns exist regarding its potential use as a biological weapon.
Purpose of the Study:
- To review current live, killed, and subunit vaccine candidates against Francisella tularensis subsp. tularensis.
- To discuss the challenges in developing an effective and licensed vaccine.
Main Methods:
- Review of recent studies on vaccine candidates tested in mouse models.
- Analysis of efficacy against respiratory challenge with Francisella tularensis subsp. tularensis.
Main Results:
- Several novel vaccine candidates have shown promise in preclinical studies.
- Existing prophylactic measures are limited and unlicensed.
Conclusions:
- Development of a licensed vaccine against Francisella tularensis subsp. tularensis remains a critical unmet need.
- Overcoming development hurdles is essential for biodefense preparedness.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:51Vaccinations
Overview
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.